# US 2019/0375803 A1 · Novel nucleoside triphosphate transporter and uses thereof

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 2019/0375803 A1
- Document ID: US20190375803A1
- Status: Published application
- Kind: A1
- Application number: 16/546,100
- Filed: 2019-08-20
- Published: 2019-12-12
- Earliest claimed: 2016-06-24
- Assignees: The Scripps Research Institute
- Applicants: The Scripps Research Institute
- Inventors: Floyd E. ROMESBERG; Yorke ZHANG
- Web page: https://patentgrep.com/patent/US20190375803A1

## CPC

- C07K 14/405: from algae
- C12N 9/22: Ribonucleases {[RNase]; Deoxyribonucleases [DNase]}
- C12N 9/224: {Class 1 CAS enzyme complex, e.g. multi-enzyme}
- C12N 15/10: Processes for the isolation, preparation or purification of DNA or RNA (chemical preparation of DNA or RNA C07H21/00; preparation of non-structural polynucleotides from microorganisms or with enzymes C12P19/34)
- C12N 15/11: DNA or RNA fragments; Modified forms thereof (DNA or RNA not used in recombinant technology, C07H21/00); {Non-coding nucleic acids having a biological activity}
- C12N 15/90: Stable introduction of foreign DNA into chromosome
- C12N 2310/20: involving clustered regularly interspaced short palindromic repeats [CRISPR]
- C12N 2800/80: Vectors containing sites for inducing double-stranded breaks, e.g. meganuclease restriction sites
- C07K: PEPTIDES (peptides in foodstuffs A23; obtaining protein compositions for foodstuffs, working-up proteins for foodstuffs A23J; preparations for medicinal purposes A61K; peptides containing beta-lactam rings C07D; cyclic dipeptides not having in their molecule any other peptide link than those which form their ring, e.g. piperazine-2,5-diones, C07D; ergot alkaloids of the cyclic peptide type C07D519/02; macromolecular compounds having statistically distributed amino acid units in their molecules, i.e. when the preparation does not provide for a specific; but for a random sequence of the amino acid units, homopolyamides and block copolyamides derived from amino acids C08G69/00; macromolecular products derived from proteins C08H1/00; preparation of glue or gelatine C09H; single cell proteins, enzymes C12N; genetic engineering processes for obtaining peptides C12N15/00; compositions for measuring or testing processes involving enzymes C12Q; investigation or analysis of biological material G01N33/00)
- C12N: MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA (microbiological testing media C12Q1/00)

## Abstract

Disclosed herein are proteins, methods, cells, engineered microorganisms, and kits for generating a modified nucleoside triphosphate transporter from Phaeodactylum tricornutum. Also disclosed herein proteins, methods, cells, engineered microorganisms, and kits for production of a nucleic acid molecule that comprises an unnatural nucleotide utilizing a modified nucleoside triphosphate transporter from Phaeodactylum tricornutum.

## Claims

### Claim 1

A method of increasing production of a nucleic acid molecule in a cell, comprising:
(a) expressing in the cell a recombinant nucleoside triphosphate transporter, wherein the recombinant nucleoside triphosphate transporter comprises an amino acid sequence comprising a deletion,
(b) incubating the cell with one or more unnatural nucleoside triphosphates, and
(c) transporting the one or more unnatural nucleoside triphosphates into the cell using the recombinant nucleoside triphosphate transporter.

### Claim 2 (depends on 1)

The method of claim 1, wherein the nucleic acid molecule comprises DNA.

### Claim 3 (depends on 1)

The method of claim 1, wherein the nucleic acid molecule comprises RNA.

### Claim 4 (depends on 1)

The method of claim 1, wherein the recombinant nucleoside triphosphate transporter is from Phaeodactylum tricornutum.

### Claim 5 (depends on 1)

The method of claim 1, wherein the deletion comprises about 5, 10, 15, 20, 22, 25, 30, 40, 44, 50, 60, 65, 66, 70, or more amino acid residues.

### Claim 6 (depends on 1)

The method of claim 1, wherein the deletion is a N-terminal deletion.

### Claim 7 (depends on 1)

The method of claim 1, wherein the amino acid sequence of the recombinant nucleoside triphosphate transporter is at least 80%, at least 85%, at least 90%, at least 95%, at least 99%, or at least 100% identical to SEQ ID NO: 4.

### Claim 8 (depends on 1)

The method of claim 1, wherein the cell is an engineered cell.

### Claim 9 (depends on 8)

The method of claim 8, wherein the engineered cell is E. coli.

### Claim 10 (depends on 1)

The method of claim 1, wherein the cell is a prokaryotic cell.

### Claim 11 (depends on 10)

The method of claim 10, wherein the cell is E. coli.

### Claim 12 (depends on 1)

The method of claim 1, wherein the nucleic acid molecule comprises one or more unnatural nucleotides comprising a base selected from the group consisting of

### Claim 13 (depends on 1)

The method of claim 1, wherein the nucleic acid molecule comprises one or more unnatural nucleotides comprising a base which is

### Claim 14 (depends on 1)

The method of claim 1, wherein the nucleic acid molecule comprises one or more unnatural nucleotides comprising a base which is

### Claim 15 (depends on 1)

The method of claim 1, wherein the one or more unnatural nucleoside triphosphates comprises a base selected from the group consisting of

### Claim 16 (depends on 1)

The method of claim 1, wherein the one or more unnatural nucleoside triphosphates comprises a base which is

### Claim 17 (depends on 1)

The method of claim 1, wherein the one or more unnatural nucleoside triphosphates comprises a base which is

### Claim 18

A method of increasing production of a DNA nucleic acid molecule in a cell comprising:
(a) expressing in the cell a recombinant nucleoside triphosphate transporter, wherein the recombinant nucleoside triphosphate transporter comprises an amino acid sequence comprising a deletion,
(b) incubating the cell with one or more unnatural 2′-deoxyribonucleoside triphosphates, and
(c) transporting the one or more unnatural 2′-deoxyribonucleoside triphosphates into the cell using the recombinant nucleoside triphosphate transporter, wherein the one or more unnatural 2′-deoxyribonucleoside triphosphates comprise a base selected from the group consisting of:

### Claim 19 (depends on 18)

The method of claim 18, wherein the cell is E. coli.

### Claim 20 (depends on 18)

The method of claim 18, wherein the recombinant nucleoside triphosphate transporter is from Phaeodactylum tricornutum.

### Claim 21 (depends on 18)

The method of claim 18, wherein the deletion comprises about 5, 10, 15, 20, 22, 25, 30, 40, 44, 50, 60, 65, 66, 70, or more amino acid residues.

### Claim 22 (depends on 18)

The method of claim 18, wherein the deletion is a N-terminal deletion.

### Claim 23 (depends on 18)

The method of claim 18, wherein the amino acid sequence of the recombinant nucleoside triphosphate transporter is at least 80%, at least 85%, at least 90%, at least 95%, at least 99%, or at least 100% identical to SEQ ID NO: 4.

### Claim 24

A method of increasing production of a RNA nucleic acid molecule in a cell, comprising:
(a) expressing in the cell a recombinant nucleoside triphosphate transporter, wherein the recombinant nucleoside triphosphate transporter comprises an amino acid sequence comprising a deletion,
(b) incubating the cell with one or more unnatural ribonucleoside triphosphates, and
(c) transporting the one or more unnatural ribonucleoside triphosphates into the cell using the recombinant nucleoside triphosphate transporter, wherein the one or more unnatural ribonucleoside triphosphates comprise a base selected from the group consisting of:

### Claim 25 (depends on 24)

The method of claim 24, wherein the cell is E. coli.

### Claim 26 (depends on 24)

The method of claim 24, wherein the recombinant nucleoside triphosphate transporter is from Phaeodactylum tricornutum.

### Claim 27 (depends on 24)

The method of claim 24, wherein the deletion comprises about 5, 10, 15, 20, 22, 25, 30, 40, 44, 50, 60, 65, 66, 70, or more amino acid residues.

### Claim 28 (depends on 24)

The method of claim 24, wherein the deletion is a N-terminal deletion.

### Claim 29 (depends on 24)

The method of claim 24, wherein the amino acid sequence of the recombinant nucleoside triphosphate transporter is at least 80%, at least 85%, at least 90%, at least 95%, at least 99%, or at least 100% identical to SEQ ID NO: 4.
